Table 1. Basic characteristics of the enrolled patients.
| Variables | No. (%) |
|---|---|
| Age (years) | |
| <50 | 61 (21) |
| ≥50 | 235 (79) |
| Tumor size (mm) | |
| <20 | 143 (48) |
| ≥20 | 153 (52) |
| Estrogen receptor | |
| Negative | 43 (15) |
| Positive | 253 (85) |
| Progesterone receptor | |
| Negative | 74 (25) |
| Positive | 222 (75) |
| HER2 | |
| Negative | 49 (17) |
| Positive | 247 (83) |
| Lymph node involvement | |
| Negative | 209 (71) |
| Positive | 87 (29) |
| Nuclear grade | |
| 1–2 | 203 (69) |
| 3 | 93 (31) |
| CRP (mg/dL) | |
| <0.37 | 268 (91) |
| ≥0.37 | 28 (9) |
| LMR | |
| <4.56 | 46 (16) |
| ≥4.56 | 250 (84) |
| NLR | |
| <2.06 | 159 (54) |
| ≥2.06 | 137 (46) |
| PLR | |
| <162.28 | 212 (72) |
| ≥162.28 | 84 (28) |
Abbreviations: No, number; HER2, human epidermal growth factor receptor 2; CRP, C-reactive protein; LMR, lymphocyte-to-monocyte ratio; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio.